The advocacy activities of the ACR are guided by comprehensive policy statements that are developed by the Government Affairs Committee and approved by the Board of Directors. The statements also serve as guides to ACR policy recommendations for use by members of Congress, regulatory entities, and advocacy organizations.
Read the comprehensive document:
Each year, legislative and regulatory priorities of key importance are identified for enhanced effort. These priority issues are identified by the Government Affairs Committee and approved by the Board of Directors.
For 2013 the top advocacy priorities of the ACR address (a) access to rheumatology through more appropriate valuation of care provided by rheumatologists; (b) access to treatment by reigning in excessive cost sharing associated with specialty medications; and (c) continued discovery of new cures and innovative treatments through sustainable increases in funding for medical research.
Patient Access to Rheumatology 
Adequate Funding for Medical Research
Review other issues affecting the rheumatology community.
